Your browser does not support iframes.
Whatcom County Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Blog posts about
< Previous
1
2
3
4
5
6
7
8
Next >
Amylin Shoots Up On Takeover Rumors
March 29, 2012
Amylin Pharmaceutical (NASDAQ:AMLN) shares shot up 54.45% on rumors regarding a take-over bid by Bristol-Myers Squibb (NYSE:BMY). According to Bloomberg, which cited unnamed sources, Bristol-Myers had...
Read More
category
AMLN
,
Stocks
,
External Research
, and 3 more.
from
DailyMarkets.com
Stock Market News Briefs: Amylin Pharmaceuticals, Bristol-Myers Squibb Company, Peabody Energy, Red Hat
March 29, 2012
Shares of Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) gained 54.45% after Bloomberg reported that the diabetes drug maker had rejected a $3.5 billion takeover bid from Bristol-Myers Squibb Co....
Read More
category
Stocks
,
External Research
,
Contributor
from
DailyMarkets.com
Wednesday's NASDAQ Winners: AMLN, VRML, GLUU, ZOLT
March 29, 2012
New York, NY - March 29, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Wednesday March 28th.
Read More
category
NASDAQ:ZOLT
,
NASDAQ:GLUU
,
NASDAQ:AMLN
, and 1 more.
from
Investorideas.com newswire, stock news and business news for investors
AMLN, TNP, USHS, ARLP Among Charts to Watch
March 28, 2012
It was a definitive down day on Wall Street on Wednesday, so again, we’re going to cover longs and shorts, and some of the movers both ways. Amylin Pharmaceuticals, Inc. (AMLN) had a monster day on...
Read More
from
Charts of the Day by Harry Boxer
Technicals Confirm Definitive Down Session
March 28, 2012
The stock market indices had a definitive down day today as the price and technicals confirmed. The day started out with a little pop to the upside, particularly on the Nasdaq 100. They got right up to...
Read More
from
Harry's Hotline by Harry Boxer
Stock Market News Today: Why Annie's (NYSE: BNNY), Amylin (Nasdaq: AMLN) Soared Today
March 28, 2012
Among the biggest moves in stock market news today include an 87% gain for organic food maker Annie's Inc. (NYSE: BNNY) in its first trading day, and a 55% jump for Amylin Pharmaceuticals (Nasdaq: AMLN...
Read More
category
Article
,
Kerri Shannon
,
Wall Street
, and 3 more.
from
Money Morning
Hot Option Plays: Markets Challenged
March 28, 2012
Cusick’s Corner 03-28-2012 The action overnight in China rolled over into the US markets and the S&Ps are now challenging critical short term support levels (mentioned yesterday afternoon 1395/1400 on...
Read More
category
XLB
,
Options
,
FMCN
, and 13 more.
from
DailyMarkets.com
Amylin (AMLN) Said to Have Spurned $3.5 Billion Bristol-Myers (BMY) Bid
March 28, 2012
Amylin Pharmaceuticals Inc. (AMLN), the maker of the diabetes drug Bydureon, rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb Co. (BMY) earlier this year, according to two...
Read More
category
Video
,
Latest
,
Wall Street
, and 1 more.
from
Wall Street Pit
EU Label Expansion For Amylin Drug
March 26, 2012
Type II diabetes treatment, Byetta (exenatide), recently received a label expansion in the EU. Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and Eli Lilly and Company (NYSE:LLY) said that the European...
Read More
category
AMLN
,
Stocks
,
External Research
, and 2 more.
from
DailyMarkets.com
(ALKS) Risk-Reward Balanced at Alkermes
March 07, 2012
We are maintaining a Neutral rating on Alkermes (ALKS) with a target price of $18.00. Last month,... Visit StockBlogHub to view complete post.
Read More
category
AMLN
,
ELN
,
ALKS
, and 7 more.
from
Stock Blog Hub
Risk-Reward Balanced At Alkermes
March 06, 2012
We are maintaining a Neutral rating on Alkermes (NASDAQ:ALKS) with a target price of $18.00. Last month, Alkermes released its third quarter fiscal 2012 (ended December 31, 2011) financial results. ...
Read More
category
AMLN
,
ELN
,
ALKS
, and 4 more.
from
DailyMarkets.com
Amylin’s Bydureon Launches In The US
February 15, 2012
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and Alkermes plc (NASDAQ:ALKS) recently announced the availability of their type II diabetes treatment, Bydureon (exenatide once-weekly) in the US. Bydureon,...
Read More
category
AMLN
,
ALKS
,
Stocks
, and 4 more.
from
DailyMarkets.com
Hot Option Plays: When Markets Disagree
February 14, 2012
Cusick’s Corner 02-14-2012 The market was able to recover most of the midday pullback but bond yields finished close to the worst levels of the trading session, which is confusing since the bond yields...
Read More
category
AMLN
,
ZNGA
,
Options
, and 9 more.
from
DailyMarkets.com
Michael Kors Options On Trend After Earnings Blowout
February 14, 2012
Today’s tickers: KORS, AMLN & ACI KORS - Michael Kors Holdings Ltd. – A number of options strategists appear to have benefitted handsomely from bullish positions held in the House of Kors today, with...
Read More
category
AMLN
,
KORS
,
Uncategorized
, and 1 more.
from
Phil’s Stock World
Several analysts weighed in on AMLN
February 07, 2012
After the close last night, Amylin Pharmaceuticals, Inc. (AMLN - 17.61) took its turn in the earnings spotlight, unveiling a fourth-quarter loss of %24461.5 million, or %243.15 per share, down from a...
Read More
category
AMLN
from
SchaeffersResearch.com Market Observations
Revenues Skyrocket At Merged Alkermes
February 03, 2012
Alkermes plc (NASDAQ:ALKS) reported earnings of 1 cent per share (excluding merger related costs and amortization of acquired intangible assets) in the third quarter of fiscal 2012 (ending March 31,...
Read More
category
AMLN
,
ELN
,
ALKS
, and 5 more.
from
DailyMarkets.com
ZNGA, AMLN, YOKU, RAX Among Charts to Watch
February 03, 2012
Despite the fact that the market had its ups and downs on Thursday, there were a lot of stocks that we follow that did very well, so we’ll go over some of those. Zynga Inc. (ZNGA), the new IPO for...
Read More
from
Charts of the Day by Harry Boxer
Hot Option Plays: How Long Can This Grind Continue?
February 02, 2012
Cusick’s Corner As I noted in the Midday and other Corners over the past week, today’s type of action, a grind in a tight range is something that a Bull might like to see at this stage. While the S&Ps...
Read More
category
AMLN
,
Options
,
GLD
, and 9 more.
from
DailyMarkets.com
Hot Option Plays: Crude Slumps
February 01, 2012
Cusick’s Corner The market held up into the close, with the S&Ps finishing off the highs and below the resistance level that I wrote about last week, 1325. The Crude market, USO, finished below $97.50...
Read More
category
AMLN
,
Options
,
ATPG
, and 11 more.
from
DailyMarkets.com
New Study For Alkermes’ Vivitrol
February 01, 2012
Alkermes plc (NASDAQ:ALKS) recently announced the commencement of an open-label pilot study (n=30) of Vivitrol in adult prisoners who have a history of pre-incarceration of opioid dependence, a chronic...
Read More
category
AMLN
,
ELN
,
ALKS
, and 4 more.
from
DailyMarkets.com
Zyprexa Pulls Down Lilly’s 4Q Sales
January 31, 2012
Eli Lilly & Company (NYSE:LLY) reported fourth quarter 2011 adjusted earnings per share of 87 cents, 7 cents above the Zacks Consensus Estimate but 24 cents below the year-ago earnings of $1.11. The...
Read More
category
AMLN
,
jnj
,
ALKS
, and 4 more.
from
DailyMarkets.com
Stock Market News Briefs: Amylin Pharmaceuticals, Gannett Co., Thomas & Betts, USX Corporation
January 31, 2012
Share prices of drug developer Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) surged 17.46% to close at $14.26 after U.S. regulators approved a version of the company’s diabetes drug Shares of auto...
Read More
category
AMLN
,
TNB
,
GCI
, and 4 more.
from
DailyMarkets.com
Indices Recover to Close Well Off Lows
January 30, 2012
The stock market indices started off narrowly mixed this week. They were very volatile and opened sharply lower, but had a fantastic recovery to “thwart the bears,” as they say. There were large gap...
Read More
from
Harry's Hotline by Harry Boxer
Hot Option Plays: Market Drifts Lower – EU In Focus
January 30, 2012
Cusick’s Corner To correct or not correct? – that is the question some traders are asking themselves about what the market may do this new trading week. Large cap indices, S&P/NAZ, have been performing...
Read More
category
AMLN
,
UPL
,
Options
, and 11 more.
from
DailyMarkets.com
Third Time Lucky For Amylin’s Bydureon
January 30, 2012
It proved to be third time lucky for Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and Alkermes plc (NASDAQ:ALKS) with the companies finally gaining US Food and Drug Administration (FDA) approval for...
Read More
category
Stocks
,
External Research
,
Contributor
from
DailyMarkets.com
Amylin Provides Strategy Update
January 10, 2012
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) recently presented an update on its strategy for 2012 at the 30th Annual J.P. Morgan (NYSE:JPM) Healthcare Conference. Amylin has a big regulatory event...
Read More
category
AMLN
,
JPM
,
Stocks
, and 4 more.
from
DailyMarkets.com
Upgrades & Downgrades: GM, AMLN, ISRG, SAM, and TTWO
January 05, 2012
Analysts are weighing in today on Detroit icon General Motors Company (GM - 21.23), drug company Amylin Pharmaceuticals, Inc...( Read More )
Read More
category
AMLN
from
SchaeffersResearch.com Trading Floor Blog
New Ratings (MMM, AMLN, BSFT, CE, CBE, GE, HON, ITW, INFI, IR, ISRG, PPG, RAH, ROK, SPX, SWK, SHOO, VMW)
January 05, 2012
New York, January 5th (TradersHuddle.com) – Following are some of the new analyst ratings before the market open. Research Firms Initiate: 3M (<a href="http://www. Read More --
Read More
from
TradersHuddle.com
The Q1 2012 FDA Trades
January 04, 2012
Be in the right place at the right time
Read More
from
Wealth Daily
Global Hunter Securities started AMLN with an 'accumulate' rating
December 07, 2011
Amylin Pharmaceuticals Inc. (AMLN - 10.77) this morning was started with an "accumulate" rating by Global Hunter Securities...( Read More )
Read More
category
AMLN
from
SchaeffersResearch.com Market Observations
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.